comparemela.com

Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering CLAR-121 (Testosterone + Anastrozole) for Treatment of Androgen-Mediated Autoimmune Inflammatory Mastitis

Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering CLAR-121 (Testosterone + Anastrozole) for Treatment of Androgen-Mediated Autoimmune Inflammatory Mastitis

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States ,Kara Stancellvice ,Robert Dudley ,Exchange Commission ,Trademark Office ,Drug Administration ,Clarus Therapeutics Holdings Inc ,Investor Relations Corporate Communications ,Orphan Drug Designation ,Therapeutics Holdings ,United States Patent ,Androgenic Agent ,Aromatase Inhibitor ,Sustained Multi Phasic Release Profiles ,Chief Executive Officer ,Inflammatory Periductal Mastitis ,Australia Based Havah Therapeutics ,Clarus Therapeutics Holdings ,Inc Clarus Therapeutics Holdings ,Clarus Therapeutics ,Forward Looking Statementscertain ,Kara Stancellvice President ,Investor Relations ,Corporate Communications ,

comparemela.com © 2020. All Rights Reserved.